Expression of vascular endothelial growth factor in sera and lymph nodes of the plasma cell type of Castleman's disease

被引:76
作者
Nishi, J
Arimura, K
Utsunomiya, A
Yonezawa, S
Kawakami, K
Maeno, N
Ijichi, O
Ikarimoto, N
Nakata, M
Kitajima, I
Fukushige, T
Takamatsu, H
Miyata, K
Maruyama, I
机构
[1] Kagoshima Univ, Fac Med, Dept Paediat, Kagoshima 8908520, Japan
[2] Kagoshima Univ, Fac Med, Dept Internal Med 3, Kagoshima 8908520, Japan
[3] Kagoshima Univ, Fac Med, Dept Pathol 2, Kagoshima 8908520, Japan
[4] Kagoshima Univ, Fac Med, Dept Clin Lab Med, Kagoshima 8908520, Japan
[5] Kagoshima Univ, Fac Med, Dept Paediat Surg, Kagoshima 8908520, Japan
[6] Imamura Bun In Hosp, Dept Haematol, Kagoshima, Japan
关键词
vascular endothelial growth factor; lymph node; vascular proliferation; Castleman's disease; plasma cell type;
D O I
10.1046/j.1365-2141.1999.01208.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate the possible involvement of vascular endothelial growth factor (VEGF) in the pathogenesis of Castleman's disease, we studied VEGF levels in sera and supernatants of cultured lymph nodes from two patients with the plasma cell type of Castleman's disease, and analysed the expression of VEGF immunohistochemically in the lymph nodes. Clinically, one patient was classified as the localized type and the other as the multicentric type. Histologically, mature plasma cells and hyalinized vessels were prominent in the interfollicular region. The VEGF levels of the sera and the supernatants of cultured lymph nodes of both patients were higher than those of normal controls. VEGF was strongly expressed in plasma cells in the interfollicular region of the lymph nodes of both patients, but rarely in normal lymph nodes. Our results suggest that VEGF may be involved in the marked vascular proliferation in the interfollicular region of the lymph nodes of the plasma cell type of Castleman's disease.
引用
收藏
页码:482 / 485
页数:4
相关论文
共 23 条
[1]   CASE-REPORT - CASTLEMAN DISEASE IN ASSOCIATION WITH POEMS [J].
ADELMAN, HM ;
CACCIATORE, ML ;
PASCUAL, JF ;
MIKE, JM ;
ALBERTS, WM ;
WALLACH, PM .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1994, 307 (02) :112-114
[2]  
CASTLEMAN B, 1956, CANCER, V9, P822, DOI 10.1002/1097-0142(195607/08)9:4<822::AID-CNCR2820090430>3.0.CO
[3]  
2-4
[4]   Interleukin 6 induces the expression of vascular endothelial growth factor [J].
Cohen, T ;
Nahari, D ;
Cerem, LW ;
Neufeld, G ;
Levi, BZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :736-741
[5]  
Foss HD, 1997, J PATHOL, V183, P44, DOI 10.1002/(SICI)1096-9896(199709)183:1<44::AID-PATH1103>3.0.CO
[6]  
2-I
[7]  
GABA AR, 1978, AM J CLIN PATHOL, V69, P86
[8]  
GHERARDI RK, 1994, BLOOD, V83, P2587
[9]  
GHERARDI RK, 1991, ANN INTERN MED, V114, P520, DOI 10.7326/0003-4819-114-6-520
[10]   SENSITIVE CHEMILUMINESCENCE ENZYME-IMMUNOASSAY FOR VASCULAR ENDOTHELIAL GROWTH-FACTOR VASCULAR-PERMEABILITY FACTOR IN HUMAN SERUM [J].
HANATANI, M ;
TANAKA, Y ;
KONDO, S ;
OHMORI, I ;
SUZUKI, H .
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 1995, 59 (10) :1958-1959